Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate -Specific Antigen Working Group
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Clinical trials for patients in the state of a rising prostate-specific antigen |
| Full bibliographic reference | Scher HI, Eisenberger M, D'Amico AV, Halabi S, Small EJ, Morris M, Kattan MW, Roach M, Kantoff P, Pienta KJ, Carducci MA, Agus D, Slovin SF, Heller G, Kelly WK, Lange PH, Petrylak D, Berg W, Higano C, Wilding G, Moul JW, Partin AN, Logothetis C, Soule HR. Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 2004;22(3):537-556. |
| Language | English |
| PubMed ID | 14752077 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Oncology, Urology |
| Applies to the whole report or to individual sections of the report? | Outcomes (variables), Study characteristics (participants etc.) |
| Record last updated on | August 22, 2013 |